Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin
- 1 July 1997
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 28 (1) , 63-72
- https://doi.org/10.1016/s0920-1211(97)00031-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trialEpilepsy Research, 1995
- The γ-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsyEuropean Journal of Pharmacology, 1995
- Efficacy and tolerability of tiagabine: Results of an add-on study in patients with refractory partial seizuresJournal of Epilepsy, 1995
- Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1European Journal of Pharmacology: Molecular Pharmacology, 1994
- New Antiepileptic DrugsCNS Drugs, 1994
- An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channelsPublished by Elsevier ,1992
- The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake ratsEuropean Journal of Pharmacology, 1992
- Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitorEuropean Journal of Pharmacology, 1991
- (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake CarrierJournal of Neurochemistry, 1990
- Published by Elsevier ,1983